Alnylam Pharmaceuticals
ALNY
#637
Rank
NZ$54.40 B
Marketcap
$420.22
Share price
-0.07%
Change (1 day)
74.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company